journal cover

Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide

Annals of the Rheumatic Diseases

Jan 17, 2009

Jeffrey R CurtisJoel M Kremer

Abstract

Potential hepatotoxicity associated with disease-modifying antirheumatic drugs (DMARDs) requires laboratory monitoring. In patients with rheumatoid arthritis (RA) or psoriatic arthritis (PsA), the incidence of elevated alanine aminotransferase/aspartate aminotransferase (ALT/AST) enzyme...read more

Mentioned in this Paper

Leflunomide
Antirheumatic Drugs, Disease-Modifying
Enzymes, antithrombotic
Clinical Enzyme Tests (Procedure)
SU101
Incidence Studies
Drug-Induced Acute Liver Injury
Polychemotherapy
Rheumatoid Arthritis
Isoxazoles
1
78
Paper Details
References
  • References12
  • Citations55
12
  • References12
  • Citations55
12345...

Similar Papers Found In These Feeds

Liver Safety Biomarkers

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on liver safety biomarkers.

Immunosuppression

Immunosuppression trends for solid organ transplantation have undergone a perceptible shift over the past decade. Discover the latest research on immunosuppression here.

Related Papers

Nature Reviews. Rheumatology

Hepatotoxicity related to antirheumatic drugs

Nature Reviews. RheumatologyJanuary 26, 2011
Guruprasad P Aithal
Drug Safety : an International Journal of Medical Toxicology and Drug Experience

Leflunomide for the treatment of rheumatoid arthritis in clinical practice: incidence and severity of hepatotoxicity

Drug Safety : an International Journal of Medical Toxicology and Drug ExperienceApril 6, 2004
Eric N van RoonJacobus R B J Brouwers
© 2020 Meta ULC. All rights reserved

Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide

Annals of the Rheumatic Diseases

Jan 17, 2009

Jeffrey R CurtisJoel M Kremer

PMID: 19147616

DOI: 10.1136/ard.2008.101378

Abstract

Potential hepatotoxicity associated with disease-modifying antirheumatic drugs (DMARDs) requires laboratory monitoring. In patients with rheumatoid arthritis (RA) or psoriatic arthritis (PsA), the incidence of elevated alanine aminotransferase/aspartate aminotransferase (ALT/AST) enzyme...read more

Mentioned in this Paper

Leflunomide
Antirheumatic Drugs, Disease-Modifying
Enzymes, antithrombotic
Clinical Enzyme Tests (Procedure)
SU101
Incidence Studies
Drug-Induced Acute Liver Injury
Polychemotherapy
Rheumatoid Arthritis
Isoxazoles
1
78

Similar Papers Found In These Feeds

Liver Safety Biomarkers

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on liver safety biomarkers.

Immunosuppression

Immunosuppression trends for solid organ transplantation have undergone a perceptible shift over the past decade. Discover the latest research on immunosuppression here.

Related Papers

Nature Reviews. Rheumatology

Hepatotoxicity related to antirheumatic drugs

Nature Reviews. RheumatologyJanuary 26, 2011
Guruprasad P Aithal
Drug Safety : an International Journal of Medical Toxicology and Drug Experience

Leflunomide for the treatment of rheumatoid arthritis in clinical practice: incidence and severity of hepatotoxicity

Drug Safety : an International Journal of Medical Toxicology and Drug ExperienceApril 6, 2004
Eric N van RoonJacobus R B J Brouwers
Paper Details
References
  • References12
  • Citations55
12
  • References12
  • Citations55
12345...
/papers/elevated-liver-enzyme-tests-among-patients-with/19147616